Bentham Science Logo

Current Drug Targets

Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Drug Targets, Volume 7 - Number 3







Targeting JAK3 and BTK Tyrosine Kinases with Rationally-Designed Inhibitors

, 7(3): 327 - 343

Alexei O. Vassilev, Heather E. Tibbles, Darin DuMez, Taracad K. Venkatachalam and Fatih M. Uckun


DOI: 10.2174/138945006776054997




Clinical Aspects of Natural Anti-Angiogenic Drugs

, 7(3): 371 - 383

C. P. Neal, D. P. Berry, H. Doucas, M. M. Manson, W. Steward and G. Garcea


DOI: 10.2174/138945006776054951




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 2.19

Related Journals

Related eBooks

eBooks Catalog